989 related articles for article (PubMed ID: 22789542)
1. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.
Schlacher K; Wu H; Jasin M
Cancer Cell; 2012 Jul; 22(1):106-16. PubMed ID: 22789542
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
[TBL] [Abstract][Full Text] [Related]
4. FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability.
Liu W; Polaczek P; Roubal I; Meng Y; Choe WC; Caron MC; Sedgeman CA; Xi Y; Liu C; Wu Q; Zheng L; Masson JY; Shen B; Campbell JL
Nucleic Acids Res; 2023 Sep; 51(17):9144-9165. PubMed ID: 37526271
[TBL] [Abstract][Full Text] [Related]
5. CtIP mediates replication fork recovery in a FANCD2-regulated manner.
Yeo JE; Lee EH; Hendrickson EA; Sobeck A
Hum Mol Genet; 2014 Jul; 23(14):3695-705. PubMed ID: 24556218
[TBL] [Abstract][Full Text] [Related]
6. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
[TBL] [Abstract][Full Text] [Related]
7. SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells.
Okamoto Y; Abe M; Mu A; Tempaku Y; Rogers CB; Mochizuki AL; Katsuki Y; Kanemaki MT; Takaori-Kondo A; Sobeck A; Bielinsky AK; Takata M
Blood; 2021 Jan; 137(3):336-348. PubMed ID: 32735670
[TBL] [Abstract][Full Text] [Related]
8. Fanconi-Anemia-Associated Mutations Destabilize RAD51 Filaments and Impair Replication Fork Protection.
Zadorozhny K; Sannino V; Beláň O; Mlčoušková J; Špírek M; Costanzo V; Krejčí L
Cell Rep; 2017 Oct; 21(2):333-340. PubMed ID: 29020621
[TBL] [Abstract][Full Text] [Related]
9. FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.
Raghunandan M; Chaudhury I; Kelich SL; Hanenberg H; Sobeck A
Cell Cycle; 2015; 14(3):342-53. PubMed ID: 25659033
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
11. RADX Modulates RAD51 Activity to Control Replication Fork Protection.
Bhat KP; Krishnamoorthy A; Dungrawala H; Garcin EB; Modesti M; Cortez D
Cell Rep; 2018 Jul; 24(3):538-545. PubMed ID: 30021152
[TBL] [Abstract][Full Text] [Related]
12. Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.
Raghunandan M; Yeo JE; Walter R; Saito K; Harvey AJ; Ittershagen S; Lee EA; Yang J; Hoatlin ME; Bielinsky AK; Hendrickson EA; Schärer O; Sobeck A
Hum Mol Genet; 2020 May; 29(7):1083-1095. PubMed ID: 31628488
[TBL] [Abstract][Full Text] [Related]
13. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
14. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25847274
[TBL] [Abstract][Full Text] [Related]
15. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25773776
[TBL] [Abstract][Full Text] [Related]
16. The
Kolinjivadi AM; Sankar H; Choudhary R; Tay LS; Tan TZ; Murata-Kamiya N; Voon DC; Kappei D; Hatakeyama M; Krishnan V; Ito Y
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163588
[TBL] [Abstract][Full Text] [Related]
17. Exploring the link between MORF4L1 and risk of breast cancer.
Martrat G; Maxwell CM; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gómez-Baldó L; Bogliolo M; Lázaro C; Blanco I; Brunet J; Aguilar H; Fernández-Rodríguez J; Seal S; Renwick A; Rahman N; Kühl J; Neveling K; Schindler D; Ramírez MJ; Castellà M; Hernández G; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong KR; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; ; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MG; van Os TA; Blok MJ; Meijers-Heijboer HE; Hogervorst FB; ; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; ; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldés T; Osorio A; Benítez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Ferrer SF; Collonge-Rame MA; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Cerón J; Tominaga K; Surrallés J; Pujana MA
Breast Cancer Res; 2011 Apr; 13(2):R40. PubMed ID: 21466675
[TBL] [Abstract][Full Text] [Related]
18. Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
Kolinjivadi AM; Sannino V; De Antoni A; Zadorozhny K; Kilkenny M; Técher H; Baldi G; Shen R; Ciccia A; Pellegrini L; Krejci L; Costanzo V
Mol Cell; 2017 Sep; 67(5):867-881.e7. PubMed ID: 28757209
[TBL] [Abstract][Full Text] [Related]
19. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
[TBL] [Abstract][Full Text] [Related]
20. Isomerization of BRCA1-BARD1 promotes replication fork protection.
Daza-Martin M; Starowicz K; Jamshad M; Tye S; Ronson GE; MacKay HL; Chauhan AS; Walker AK; Stone HR; Beesley JFJ; Coles JL; Garvin AJ; Stewart GS; McCorvie TJ; Zhang X; Densham RM; Morris JR
Nature; 2019 Jul; 571(7766):521-527. PubMed ID: 31270457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
